Literature DB >> 21747661

Diastolic dysfunction without abnormalities in left atrial and left ventricular geometry does not affect quality of life in elderly women.

Alfried Germing1, Michael Gotzmann, Tamara Schikowski, Andrea Vierkötter, Ulrich Ranft, Andreas Mügge.   

Abstract

BACKGROUND/AIMS: Advanced age and female sex are associated with increased myocardial stiffness, even in the absence of cardiovascular disease. Left ventricular (LV) hypertrophy and left atrial (LA) enlargement are typical findings in patients with LV diastolic dysfunction (DD). Because DD has been described in asymptomatic subjects, its clinical impact remains controversial. It has previously been hypothesized that mild DD has no clinical impact when natriuretic peptide levels are normal. The present study aimed to determine the impact of LA volume and LV mass on DD in elderly women. METHODS AND
RESULTS: A cross-sectional survey was used to investigate a cohort of 311 randomly selected, nonhospitalized elderly women (mean [± SD] age 74.3±2.9 years). Examination comprised quality of life, measurement of brain natriuretic peptide (BNP) levels and echocardiography. The prevalences of different degrees of DD were as follows: mild 47.9% (n=149), moderate 36.7% (n=114) and severe 4.8% (n=15). Compared with normal diastolic function, moderate and severe DD were associated with higher BNP levels (P=0.038 and P<0.001, respectively) and elevated indexes of LA volume (LAVI) (P=0.007 and P<0.001, respectively) and LV mass (LVMI) (P=0.074 and P=0.017, respectively). Participants with normal diastolic function and mild DD had no significant differences in quality of life, BNP levels, LAVI or LVMI.
CONCLUSION: Mild DD is common in elderly women and is not associated with increased BNP levels or poor quality of life. Compared with individuals with moderate and severe DD, LAVI and LVMI are normal in patients with mild DD.

Entities:  

Keywords:  Diastolic dysfunction; Elderly women; Left atrial volume; Left ventricular mass

Year:  2011        PMID: 21747661      PMCID: PMC3126680     

Source DB:  PubMed          Journal:  Exp Clin Cardiol        ISSN: 1205-6626


  30 in total

1.  Increased left atrial volume index is an independent predictor of raised serum natriuretic peptide in patients with suspected heart failure but normal left ventricular ejection fraction: Implication for diagnosis of diastolic heart failure.

Authors:  Tiong K Lim; Houman Ashrafian; Girish Dwivedi; Paul O Collinson; Roxy Senior
Journal:  Eur J Heart Fail       Date:  2005-08-22       Impact factor: 15.534

Review 2.  Recommendations for the evaluation of left ventricular diastolic function by echocardiography.

Authors:  Sherif F Nagueh; Christopher P Appleton; Thierry C Gillebert; Paolo N Marino; Jae K Oh; Otto A Smiseth; Alan D Waggoner; Frank A Flachskampf; Patricia A Pellikka; Arturo Evangelisa
Journal:  Eur J Echocardiogr       Date:  2009-03

3.  Tissue Doppler analysis of age-dependency in diastolic ventricular behaviour and filling: a cross-sectional study of healthy hearts (the Umeå General Population Heart Study).

Authors:  M Henein; P Lindqvist; D Francis; S Mörner; A Waldenström; E Kazzam
Journal:  Eur Heart J       Date:  2002-01       Impact factor: 29.983

4.  Importance of heart failure with preserved systolic function in patients > or = 65 years of age. CHS Research Group. Cardiovascular Health Study.

Authors:  D W Kitzman; J M Gardin; J S Gottdiener; A Arnold; R Boineau; G Aurigemma; E K Marino; M Lyles; M Cushman; P L Enright
Journal:  Am J Cardiol       Date:  2001-02-15       Impact factor: 2.778

5.  Left atrial volume is an independent predictor of exercise capacity in patients with isolated left ventricular diastolic dysfunction.

Authors:  Raymond Ching-Chiew Wong; Tiong Cheng Yeo
Journal:  Int J Cardiol       Date:  2009-04-08       Impact factor: 4.164

6.  BNP and NT-proBNP predict echocardiographic severity of diastolic dysfunction.

Authors:  Jasmine Grewal; Robert McKelvie; Eva Lonn; Peter Tait; Jonas Carlsson; Monica Gianni; Christina Jarnert; Hans Persson
Journal:  Eur J Heart Fail       Date:  2008-03       Impact factor: 15.534

7.  Impact of left ventricular diastolic dysfunction on left atrial volume and function: a volumetric analysis.

Authors:  Swee Guan Teo; Hilda Yang; Ping Chai; Tiong Cheng Yeo
Journal:  Eur J Echocardiogr       Date:  2009-10-13

8.  Relation of left atrial maximal volume measured by real-time 3D echocardiography to demographic, clinical, and Doppler variables.

Authors:  Stefano De Castro; Stefano Caselli; Emanuele Di Angelantonio; Sara Del Colle; Francesca Mirabelli; Andrea Marcantonio; Danilo Puccio; Daria Santini; Natesa G Pandian
Journal:  Am J Cardiol       Date:  2008-03-05       Impact factor: 2.778

9.  Elevation of plasma brain natriuretic peptide is a hallmark of diastolic heart failure independent of ventricular hypertrophy.

Authors:  Hitoshi Yamaguchi; Junichi Yoshida; Kazuhiro Yamamoto; Yasushi Sakata; Toshiaki Mano; Noriyuki Akehi; Masatsugu Hori; Young-Jae Lim; Masayoshi Mishima; Tohru Masuyama
Journal:  J Am Coll Cardiol       Date:  2004-01-07       Impact factor: 24.094

10.  The correlation of left atrial volume index to the level of N-terminal pro-BNP in heart failure with a preserved ejection fraction.

Authors:  Hyungseop Kim; Dong-Whan Jun; Yun-Kyeong Cho; Chang-Wook Nam; Seong-Wook Han; Seung-Ho Hur; Yoon-Nyun Kim; Kwon-Bae Kim
Journal:  Echocardiography       Date:  2008-09-02       Impact factor: 1.724

View more
  2 in total

1.  Age- and sex-related differences in diastolic function and cardiac dimensions in a hypertensive population.

Authors:  Shiro Hoshida; Yukinori Shinoda; Kuniyasu Ikeoka; Hidetada Fukuoka; Hirooki Inui; Tetsuya Watanabe
Journal:  ESC Heart Fail       Date:  2016-07-14

2.  Relationship of left ventricular and atrial dimensions with moderate to severe left ventricular diastolic dysfunction (grade II and above).

Authors:  Muhammad Hamza; Mishal Fatima; Muhammad Masood; Hafiz Umar Masood; Ghazal Tasleem; Hassaan Ahmed; Maha Nadir; Zubair Satti
Journal:  Afr Health Sci       Date:  2020-12       Impact factor: 0.927

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.